PlaqueSlam is a precision-compounded, nine-ingredient capsule formula built around the highest clinically validated dose of nattokinase ever studied in humans: 10,800 FU per day. Developed for patients seeking a natural, aspirin-free approach to managing arterial plaque, cholesterol, and cardiovascular inflammation, PlaqueSlam combines three complementary fibrinolytic enzymes with evidence-based lipid, anti-inflammatory, and anti-calcification compounds — each selected because it has published human clinical trial data behind it, not because it sounded good on a label.
This isn't a single-ingredient supplement scaled up. It's a six-mechanism cardiovascular protocol, compounded under physician supervision, with a defined testing schedule and a documented pathway for patients looking to reduce or transition off statin therapy. 
Who PlaqueSlam Is For?
PlaqueSlam is dispensed under physician supervision as part of a structured protocol. It is generally appropriate for adults with elevated cholesterol or early-stage arterial plaque who are not on blood thinners, do not have a history of bleeding disorders, and are working with a prescribing physician to either manage cardiovascular risk naturally or explore a supervised transition away from statin therapy.
Curious whether PlaqueSlam is right for you?
PlaqueSlam is available exclusively through physician consultation. Book an assessment to review your cardiovascular risk profile and discuss whether this protocol fits your health goals.